WO2007105047A2 - Ultrasound molecular sensors and uses thereof - Google Patents
Ultrasound molecular sensors and uses thereof Download PDFInfo
- Publication number
- WO2007105047A2 WO2007105047A2 PCT/IB2007/000506 IB2007000506W WO2007105047A2 WO 2007105047 A2 WO2007105047 A2 WO 2007105047A2 IB 2007000506 W IB2007000506 W IB 2007000506W WO 2007105047 A2 WO2007105047 A2 WO 2007105047A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ultrasound
- analyte
- frequencies
- molecular sensor
- target
- Prior art date
Links
- 238000002604 ultrasonography Methods 0.000 title claims abstract description 163
- 238000000034 method Methods 0.000 claims abstract description 77
- 239000012491 analyte Substances 0.000 claims abstract description 73
- 229920000642 polymer Polymers 0.000 claims abstract description 50
- 239000000017 hydrogel Substances 0.000 claims description 48
- 230000027455 binding Effects 0.000 claims description 33
- 238000001514 detection method Methods 0.000 claims description 26
- 150000001875 compounds Chemical class 0.000 claims description 16
- 102000004169 proteins and genes Human genes 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 12
- 239000001913 cellulose Substances 0.000 claims description 11
- 229920002678 cellulose Polymers 0.000 claims description 11
- 239000000412 dendrimer Substances 0.000 claims description 9
- 229920000736 dendritic polymer Polymers 0.000 claims description 9
- 238000007912 intraperitoneal administration Methods 0.000 claims description 6
- 229920000615 alginic acid Polymers 0.000 claims description 5
- 235000010443 alginic acid Nutrition 0.000 claims description 5
- 239000008280 blood Substances 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 4
- 150000001720 carbohydrates Chemical class 0.000 claims description 4
- 235000014633 carbohydrates Nutrition 0.000 claims description 4
- 238000001727 in vivo Methods 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 4
- 102000039446 nucleic acids Human genes 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- 102000005962 receptors Human genes 0.000 claims description 4
- 108020003175 receptors Proteins 0.000 claims description 4
- 238000001361 intraarterial administration Methods 0.000 claims description 3
- 238000001990 intravenous administration Methods 0.000 claims description 3
- 238000007920 subcutaneous administration Methods 0.000 claims description 3
- 238000011065 in-situ storage Methods 0.000 claims 4
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 3
- 108091023037 Aptamer Proteins 0.000 claims 3
- 108091005461 Nucleic proteins Proteins 0.000 claims 3
- 229940072056 alginate Drugs 0.000 claims 3
- 238000000338 in vitro Methods 0.000 claims 2
- 238000007911 parenteral administration Methods 0.000 claims 2
- 230000009149 molecular binding Effects 0.000 claims 1
- 238000005259 measurement Methods 0.000 abstract description 15
- 230000008859 change Effects 0.000 abstract description 8
- 239000002872 contrast media Substances 0.000 abstract description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 123
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 76
- 229960000278 theophylline Drugs 0.000 description 61
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 38
- 229960001948 caffeine Drugs 0.000 description 38
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 38
- 239000000243 solution Substances 0.000 description 31
- 239000000523 sample Substances 0.000 description 28
- 238000002474 experimental method Methods 0.000 description 14
- 230000005540 biological transmission Effects 0.000 description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 238000011088 calibration curve Methods 0.000 description 12
- 238000001228 spectrum Methods 0.000 description 12
- 239000000499 gel Substances 0.000 description 11
- 238000011002 quantification Methods 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 9
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 9
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 9
- 230000007704 transition Effects 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 8
- 238000003384 imaging method Methods 0.000 description 7
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 6
- 238000006116 polymerization reaction Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 5
- 230000005284 excitation Effects 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 230000003595 spectral effect Effects 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000002238 attenuated effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- XJWSAJYUBXQQDR-UHFFFAOYSA-M dodecyltrimethylammonium bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)C XJWSAJYUBXQQDR-UHFFFAOYSA-M 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- SENLDUJVTGGYIH-UHFFFAOYSA-N n-(2-aminoethyl)-3-[[3-(2-aminoethylamino)-3-oxopropyl]-[2-[bis[3-(2-aminoethylamino)-3-oxopropyl]amino]ethyl]amino]propanamide Chemical compound NCCNC(=O)CCN(CCC(=O)NCCN)CCN(CCC(=O)NCCN)CCC(=O)NCCN SENLDUJVTGGYIH-UHFFFAOYSA-N 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 229920000962 poly(amidoamine) Polymers 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000012285 ultrasound imaging Methods 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- QMGYPNKICQJHLN-UHFFFAOYSA-M Carboxymethylcellulose cellulose carboxymethyl ether Chemical compound [Na+].CC([O-])=O.OCC(O)C(O)C(O)C(O)C=O QMGYPNKICQJHLN-UHFFFAOYSA-M 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 108020005351 Isochores Proteins 0.000 description 1
- 239000012901 Milli-Q water Substances 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- 230000018199 S phase Effects 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001330 spinodal decomposition reaction Methods 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
- A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
- A61K49/226—Solutes, emulsions, suspensions, dispersions, semi-solid forms, e.g. hydrogels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
- A61B8/0866—Detecting organic movements or changes, e.g. tumours, cysts, swellings involving foetal diagnosis; pre-natal or peri-natal diagnosis of the baby
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/48—Diagnostic techniques
- A61B8/481—Diagnostic techniques involving the use of contrast agent, e.g. microbubbles introduced into the bloodstream
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Epidemiology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Chemical & Material Sciences (AREA)
- Acoustics & Sound (AREA)
- Dispersion Chemistry (AREA)
- Hematology (AREA)
- Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2007226258A AU2007226258A1 (en) | 2006-03-10 | 2007-03-02 | Ultrasound molecular sensors and uses thereof |
JP2008557844A JP2009529668A (en) | 2006-03-10 | 2007-03-02 | Ultrasonic molecular sensor and use thereof |
EP07733912A EP1993447A4 (en) | 2006-03-10 | 2007-03-02 | Ultrasound molecular sensors and uses thereof |
CA002644771A CA2644771A1 (en) | 2006-03-10 | 2007-03-02 | Ultrasound molecular sensors and uses thereof |
US12/224,928 US8366625B2 (en) | 2006-03-10 | 2007-03-05 | Ultrasound molecular sensors and uses thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78082306P | 2006-03-10 | 2006-03-10 | |
US60/780,823 | 2006-03-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007105047A2 true WO2007105047A2 (en) | 2007-09-20 |
WO2007105047A3 WO2007105047A3 (en) | 2009-04-23 |
Family
ID=38509842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2007/000506 WO2007105047A2 (en) | 2006-03-10 | 2007-03-02 | Ultrasound molecular sensors and uses thereof |
Country Status (6)
Country | Link |
---|---|
US (1) | US8366625B2 (en) |
EP (1) | EP1993447A4 (en) |
JP (1) | JP2009529668A (en) |
AU (1) | AU2007226258A1 (en) |
CA (1) | CA2644771A1 (en) |
WO (1) | WO2007105047A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106233141B (en) | 2014-02-18 | 2018-08-21 | 罗伯特·I·汉金 | The method and composition of loss and/or distortion for the diagnosing and treating sense of taste or smell |
KR102373273B1 (en) * | 2017-04-18 | 2022-03-15 | 기초과학연구원 | Polymeric gel, and method of manufacturing the same, and product using the same |
KR102129986B1 (en) * | 2018-08-30 | 2020-07-03 | 포항공과대학교 산학협력단 | A pharmaceutical composition for preventing or treating inflammatory diseases comprising an acrylamide-based polymer having nitric oxide sensitivity |
WO2023122473A2 (en) * | 2021-12-21 | 2023-06-29 | Cyrano Therapeutics, Inc. | Gel treatment for loss of taste and smell |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5562099A (en) * | 1990-10-05 | 1996-10-08 | Massachusetts Institute Of Technology | Polymeric microparticles containing agents for imaging |
US5411730A (en) * | 1993-07-20 | 1995-05-02 | Research Corporation Technologies, Inc. | Magnetic microparticles |
AU716667B2 (en) * | 1996-01-10 | 2000-03-02 | Nycomed Imaging As | Contrast media |
US6193951B1 (en) * | 1997-04-30 | 2001-02-27 | Point Biomedical Corporation | Microparticles useful as ultrasonic contrast agents |
US6245318B1 (en) * | 1997-05-27 | 2001-06-12 | Mallinckrodt Inc. | Selectively binding ultrasound contrast agents |
US20050074499A1 (en) * | 1999-03-17 | 2005-04-07 | Mitsubishi Chemical Corporation | Ligand-bonded complex |
US6751491B2 (en) * | 2001-09-01 | 2004-06-15 | M Biotech Inc | Analyte measuring biosensor chip using image scanning system |
DE10215335A1 (en) * | 2002-03-28 | 2003-10-16 | Schering Ag | Device and method for quantifying bubbles |
US7329414B2 (en) * | 2002-05-03 | 2008-02-12 | Biopsy Sciences, Llc | Biodegradable polymer for marking tissue and sealing tracts |
US7769423B2 (en) * | 2002-09-11 | 2010-08-03 | Duke University | MRI imageable liposomes for the evaluation of treatment efficacy, thermal distribution, and demonstration of dose painting |
IL155866A0 (en) * | 2003-05-12 | 2003-12-23 | Yissum Res Dev Co | Responsive polymeric system |
US7906125B2 (en) * | 2003-09-18 | 2011-03-15 | Boston Scientific Scimed, Inc. | Solid or semi-solid therapeutic formulations |
AU2005220706A1 (en) * | 2004-02-10 | 2005-09-22 | Barnes-Jewish Hospital | Improved efficacy and safety of targeted particulate agents with decoy systems |
US20080019904A1 (en) * | 2004-06-29 | 2008-01-24 | Koninklijke Philips Electronics, N.V. | System For Manufacturing Micro-Sheres |
-
2007
- 2007-03-02 AU AU2007226258A patent/AU2007226258A1/en not_active Abandoned
- 2007-03-02 CA CA002644771A patent/CA2644771A1/en not_active Abandoned
- 2007-03-02 WO PCT/IB2007/000506 patent/WO2007105047A2/en active Application Filing
- 2007-03-02 EP EP07733912A patent/EP1993447A4/en not_active Withdrawn
- 2007-03-02 JP JP2008557844A patent/JP2009529668A/en active Pending
- 2007-03-05 US US12/224,928 patent/US8366625B2/en not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
See references of EP1993447A4 * |
Also Published As
Publication number | Publication date |
---|---|
AU2007226258A1 (en) | 2007-09-20 |
US20090299190A1 (en) | 2009-12-03 |
US8366625B2 (en) | 2013-02-05 |
EP1993447A2 (en) | 2008-11-26 |
CA2644771A1 (en) | 2007-09-20 |
JP2009529668A (en) | 2009-08-20 |
EP1993447A4 (en) | 2012-12-12 |
WO2007105047A3 (en) | 2009-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Choi et al. | A tissue mimicking polyacrylamide hydrogel phantom for visualizing thermal lesions generated by high intensity focused ultrasound | |
US20050085725A1 (en) | Photoacoustic assay and imaging system | |
US20100028261A1 (en) | Molecular Specific Photoacoustic Imaging | |
JPH09511163A (en) | Method and device for evaluating and analyzing bone characteristics | |
EP2257223A1 (en) | Image-based dynamic ultrasound spectrography to locate breast micro-calcification | |
WO2002015776A1 (en) | Photoacoustic assay and imaging system | |
JP2008502408A (en) | Combined ultrasound imaging and spectroscopic molecular analysis apparatus and method | |
CN101301210B (en) | Ultrasonic wave imaging system | |
JP5506998B2 (en) | Photoacoustic measuring device | |
Nakatsuka et al. | DNA-Coated Microbubbles with Biochemically-Tunable Ultrasound Contrast Activity | |
US8366625B2 (en) | Ultrasound molecular sensors and uses thereof | |
US20160262727A1 (en) | Acoustic detection of activated phase-change contrast agent | |
Yeh et al. | Shear wave measurements for evaluation of tendon diseases | |
JP2001508344A (en) | Ultrasound contrast imaging | |
JP2000500998A (en) | Method and apparatus for evaluating bone condition | |
US20080077002A1 (en) | Compounds and Methods for Combined Optical-Ultrasound Imaging | |
Devi et al. | Design, fabrication, and characterization of a<? xpp qa?> tissue-equivalent phantom for optical elastography | |
Luchies et al. | Quantitative ultrasonic characterization of diffuse scatterers in the presence of structures that produce coherent echoes | |
Sannachi et al. | Quantitative ultrasound monitoring of breast tumour response to neoadjuvant chemotherapy: comparison of results among clinical scanners | |
Hao et al. | Characterization of reperfused infarcted myocardium from high-frequency intracardiac ultrasound imaging using homodyned K distribution | |
JPH10137193A (en) | Swelling evaluation method | |
Boerner et al. | Repetitive optical coherence elastography measurements with blinking nanobombs | |
AU2011205100A1 (en) | Ultrasound molecular sensors and uses thereof | |
WO2005071437A1 (en) | Contrast dual frequency imaging | |
Hete et al. | Scattering of ultrasound from skeletal muscle tissue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07733912 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2644771 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007226258 Country of ref document: AU Ref document number: 2007733912 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008557844 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2007226258 Country of ref document: AU Date of ref document: 20070302 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12224928 Country of ref document: US |